Cargando…
The Optimal Treatment for Resectable Esophageal Cancer: A Network Meta-Analysis of 6168 Patients
The optimal treatment for resectable esophageal cancer remains unclear. This network meta-analysis compares the efficacy of different treatments. PubMed, Embase, and the Cochrane library were systematically screened. Randomized controlled trials comparing the efficacy of different treatments for res...
Autores principales: | Yuan, Meng, Bao, Yongxing, Ma, Zeliang, Men, Yu, Wang, Yang, Hui, Zhouguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988076/ https://www.ncbi.nlm.nih.gov/pubmed/33777777 http://dx.doi.org/10.3389/fonc.2021.628706 |
Ejemplares similares
-
Survival of Neoadjuvant and Adjuvant Therapy Compared With Surgery Alone for Resectable Esophageal Squamous Cell Carcinoma: A Systemic Review and Network Meta-Analysis
por: Ma, Zeliang, et al.
Publicado: (2021) -
Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta‐analysis
por: Bao, Yongxing, et al.
Publicado: (2022) -
Additional Radiotherapy With or Without Chemotherapy Following
Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot
Study
por: Yang, Xu, et al.
Publicado: (2021) -
Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis
por: Liu, Yunsong, et al.
Publicado: (2023) -
Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Bao, Yongxing, et al.
Publicado: (2022)